Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation mydrg.de

scatter_plot

Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation

• B.S.
• Dienstag, 23.06.2009

Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation (BiomedCentral).

Arzneimittel - DRG - Fallpauschalen - Kostenvergleich - URL

« Finanzspritze: 400.000 Euro fürs Krankenhaus Dorsten | Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation | Klinikum Krefeld: Spatenstich zum Neubau für 180 Millionen »